Answer
The most frequently reported adverse reactions in phase 3 trials of doravirine plus two nucleoside reverse transcriptase inhibitors were nausea (4%) and headache (3%).
Sources for this answer
- Pifeltro 100 mg film-coated tabletsMerck Sharp & Dohme (UK) Limited · emc · SmPC §4.8 Undesirable effects · Version 14Document updated
Sources checked